Balanced news tone
News Sentiment
3692 sentiment intelligence
Hansoh Pharmaceutical Group Company Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-5.2% over one week, +7.2% over four weeks, trend inactive, and materially above fair value.
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Hansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 10:19
- Source
- TipRanks
Hansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:15
- Source
- TipRanks
Hansoh Pharmaceutical Group Stock Sheds 4.2% in Hong Kong
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 08:30
- Source
- Moomoo
Hansoh Pharmaceutical Group (SEHK:3692) Wins Trial Approval, Is It Fully Priced?
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 05 Jul 2026 07:00
- Source
- simplywall.st
Results: Hansoh Pharmaceutical Group Company Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 31 Mar 2026 07:00
- Source
- simplywall.st
Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Oct 2025 07:00
- Source
- South China Morning Post
Biotheus, Hansoh ink potential ¥5B deal for new bispecific ADCs
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Mar 2024 07:00
- Source
- BioWorld News
GSK signs $1B+ licensing deal with China’s Hansoh for ADC candidate
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Oct 2023 07:00
- Source
- BioWorld News
Hang Seng review shines light on China’s 6th richest woman at Hansoh Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Aug 2022 07:00
- Source
- South China Morning Post
Technical Analysis of Hansoh Pharmaceutical Group Company Limited (HKEX:3692)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Oct 2019 04:43
- Source
- TradingView